Table 2.
Univariate Analysis of Complications
| Variable | Complication (n=35) | No Complication (n=477) | P-Value |
|---|---|---|---|
| Age (years) | 61±12 | 58±11 | 0.11 |
| Male | 18(51%) | 348(73%) | 0.01 |
| Body Mass Index (kg/m2) | 32±8 | 31±6 | 0.56 |
| Duration of AF (months) | 71±67 | 85±78 | 0.28 |
| Paroxysmal AF | 16(46%) | 222(47%) | 0.99 |
| Number of DCCV | 1±2 | 2±2 | 0.48 |
| Coronary Artery Disease | 4(11%) | 92(19%) | 0.36 |
| Obstructive Sleep Apnea | 7(20%) | 122(26%) | 0.46 |
| Clopidogrel | 1(3%) | 12(3%) | 0.90 |
| Aspirin | 11(31%) | 220(46%) | 0.09 |
| History of Amiodarone Use | 15(43%) | 170(36%) | 0.39 |
| Left Atrial Size from MRI (mm) | 39±8 | 39±8 | 0.77 |
| LVEF from MRI (%) | 68±10 | 62±12 | 0.01 |
| Redo Ablation | 5(14%) | 109(23%) | 0.24 |
| Cavotricuspid Isthmus Ablation | 8(23%) | 99(21%) | 0.77 |
| Roof Line | 15(43%) | 176(37%) | 0.48 |
| Mitral Valve Line | 7(20%) | 100(21%) | 0.89 |
| Complex Fractionated Atrial Electrogram Ablation | 3(9%) | 51(11%) | 0.69 |
| Cryoballoon | 0(0%) | 7(2%) | 0.47 |
| Procedure Time (min) | 322±94 | 285±76 | 0.05 |
Values are Mean ± SD when appropriate.